Title | Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Prasad PK, Mahajan P, Hawkins DS, Mostoufi-Moab S, Venkatramani R |
Journal | Pediatr Blood Cancer |
Pagination | e28141 |
Date Published | 2020 Apr 10 |
ISSN | 1545-5017 |
Abstract | Differentiated thyroid cancer (DTC) is the most common childhood thyroid malignancy. The standard of care for pediatric DTC is total thyroidectomy followed by radioactive iodine (RAI) treatment when indicated. Molecular changes and potential therapeutic targets have been recently described in pediatric thyroid cancer. Pediatric oncologists are increasingly involved in the evaluation of thyroid nodules in childhood cancer survivors and in the management of advanced thyroid cancer. In 2015, the American Thyroid Association published management guidelines for children with DTC. We provide an overview of the current standard of care and highlight available targeted therapies for progressive or RAI refractory DTC. |
DOI | 10.1002/pbc.28141 |
Alternate Journal | Pediatr Blood Cancer |
PubMed ID | 32275118 |